The DOI matches its Crossref record.
Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux--the "sensitive oesophagus".
Open accessAbstract
BACKGROUND: At least 10-15% of patients with reflux symptoms have a normal endoscopy and physiological levels of acid reflux on pH monitoring. Such patients with 50% or more of symptoms associated with acid reflux episodes have "a positive symptom index" (SI), and it has been proposed that this defines the "sensitive oesophagus". AIM: To test the response to omeprazole 20 mg twice daily for four weeks of patients with normal levels of acid reflux using a randomised, placebo controlled, double blind, cross-over design. PATIENTS: Eighteen patients with normal levels of reflux, 12 of whom had a positive SI. METHODS: Response was measured by symptomatic assessment and the SF-36 quality of life (QOL) questionnaire. RESULTS: Patients with a positive SI showed the following improvements on omeprazole compared with placebo: decrease in symptom frequency (p < 0.01), severity (p < 0.01) and consumption of antacids (p < 0.01). In the group with a negative SI only one patient clearly improved. The QOL parameters for bodily pain (65.6 v 53.4, p = 0.03) and vitality (60.6 v 48.8, p = 0.049) were significantly better on omeprazole than placebo for the group overall. CONCLUSION: Omeprazole improves symptoms in 11 of 18 patients with normal endoscopy and pH monitoring, particularly those with a positive SI. This supports the theory that such patients have an oesophagus which is "sensitive" to acid reflux and are part of the GORD spectrum.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Fridman, G., Friedman, G., Gutsol, A., Shekhter, A. B., Vasilets, V. N., & Fridman, A. (2008) · Plasma Processes and Polymers · doi:10.1002/ppap.200700154 · Cited by 2,084
Modern diagnosis of GERD: the Lyon Consensus
Gyawali, C. P., Kahrilas, P. J., Savarino, E., Zerbib, F., Mion, F., Smout, A. J. P. M., Vaezi, M., Sifrim, D., Fox, M. R., Vela, M. F., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-314722 · Cited by 1,457
Updated Guidelines for the Diagnosis and Treatment of Gastroesophageal Reflux Disease
DeVault, K. R., & Castell, D. O. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41217.x · Cited by 1,130
An evidence-based appraisal of reflux disease management — the Genval Workshop Report
Dent, J., Brun, J., Fendrick, A. M., Fennerty, M. B., Janssens, J., Kahrilas, P. J., Lauritsen, K., Reynolds, J. C., Shaw, M., & Talley, N. J. (1998) · Gut · doi:10.1136/gut.44.2008.s1 · Cited by 890
Alonso, J., Ferrer, M., Gandek, B., Ware, J. E., Aaronson, N. K., Mosconi, P., Rasmussen, N. K., Bullinger, M., Fukuhara, S., Kaasa, S., et al. (2004) · Quality of Life Research · doi:10.1023/b:qure.0000018472.46236.05 · Cited by 786
Metadata
- Authors
- Watson, R. G., Tham, T. C., Johnston, B. T., & McDougall, N. I.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 1997-05
- Volume
- 40
- Issue
- 5
- Pages
- 587-590
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2111647879
- Cited by
- 234
- References
- 0
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux--the "sensitive oesophagus". https://app.cochat.ai/papers/10.1136/gut.40.5.587
- The paper
- Watson, R. G., Tham, T. C., Johnston, B. T., & McDougall, N. I. (1997). Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux--the "sensitive oesophagus". Gut. https://doi.org/10.1136/gut.40.5.587
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.